Structure Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Structure Therapeutics Inc.
- Former names
- ShouTi Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GPCR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001888886
- EIN
- 98-1480821
Board of directors
-
Angus C. Russell · DirectorSince 2024
-
Daniel G. Welch · DirectorSince 2023
-
Eric Dobmeier · DirectorSince 2023
-
Joanne Waldstreicher · DirectorSince 2023
-
Ramy Farid · DirectorSince 2023
-
Raymond C. Stevens · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Sharon Tetlow · DirectorSince 2023
-
Ted W. Love · DirectorSince 2023
Chief executives
Raymond C. Stevens
· CHIEF EXECUTIVE OFFICER
Dates unknown
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.9%
-
99.7%
-
99.8%
Board connections
7 of this board's directors also sit on 14 other boards.
- via Eric Dobmeier
- via Joanne Waldstreicher
- via Raymond C. Stevens
- via Ted W. Love
- via Eric Dobmeier
- via Eric Dobmeier
- via Ted W. Love
- via Angus C. Russell
- via Daniel G. Welch
- via Daniel G. Welch
- via Ted W. Love
- via Ramy Farid
- via Daniel G. Welch
- via Ramy Farid
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 21, 2026 | Coll Crespo Blas Officer (CHIEF MEDICAL OFFICER) | Derivative conversion | −12,024 | — | — |
| Sep 18, 2026 | Coll Crespo Blas Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −10,626 | $11.67 | $124,005 |
| Sep 1, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +17,817 | $0.34 | $6,058 |
| Sep 1, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Derivative conversion | −17,817 | — | — |
| Aug 18, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +11,817 | $0.34 | $4,018 |
| Aug 18, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Derivative conversion | −11,817 | — | — |
| Aug 6, 2026 | Berrios John Joseph Officer (Chief Commercial Officer) | Grant or award | +140,766 | — | — |
| Aug 4, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +11,817 | $0.34 | $4,018 |
| Aug 4, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Derivative conversion | −11,817 | — | — |
| Jul 14, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +23,634 | $0.34 | $8,036 |
| Jul 14, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Derivative conversion | −23,634 | — | — |
| Jun 25, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +23,634 | $0.34 | $8,036 |
| Jun 25, 2026 | Lin Xichen Officer (CHIEF SCIENTIFIC OFFICER) | Derivative conversion | −23,634 | — | — |
| Apr 15, 2026 | Lang Matthew Officer (COO & GC) | Grant or award | +184,614 | — | — |
| Mar 19, 2026 | Hall Ashley Officer (Chief Development Officer) | Grant or award | +47,706 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.